2001
DOI: 10.1046/j.1468-1331.2001.00046.x
|View full text |Cite
|
Sign up to set email alerts
|

Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications

Abstract: The aim of this article is to describe our clinical experience in treating muscle imbalance in 49 children with spastic upper extremity involvement. We discuss four cohorts of children treated with botulinum toxin type A (BTX-A), each with different treatment objectives. In the first group, 27 children were treated for functional improvement and, of these, 23 had a positive effect, while four had no objective benefit. In the second group, eight children were treated for purposes of presurgical planning; of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
53
0
2

Year Published

2003
2003
2018
2018

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(55 citation statements)
references
References 11 publications
0
53
0
2
Order By: Relevance
“…It is often assumed that it is children with normal cognition who are most likely to benefit from BtA treatment [9,10], but for those with practically no voluntary control even small improvements can be valuable.…”
Section: Discussionmentioning
confidence: 99%
“…It is often assumed that it is children with normal cognition who are most likely to benefit from BtA treatment [9,10], but for those with practically no voluntary control even small improvements can be valuable.…”
Section: Discussionmentioning
confidence: 99%
“…In this group of children, treatment and intervention is often primarily focused on the lower limb, to develop and improve the walking ability of the child, with intervention for the upper limb dysfunction being secondary. However, the upper limb dysfunction can be equally disabling, affecting everyday functional tasks that involve reaching, grasping and manipulating objects [2][3][4].…”
Section: Introductionmentioning
confidence: 99%
“…While increased muscle tone or spasticity may limit overall force production and range of motion around joints, it may also contribute to enhanced joint stability [36,37]. Of interest, medical treatments commonly used for spasticity, such as botulinum toxin and oral antispasticity medications, may have the potential to either improve or inhibit sports performance given their propensity to reduce tone while concomitantly increasing muscle weakness [38,39]. It is important to realize that while such medications may change an athlete's classification, oral anti-spasticity medications are not banned from competition from an anti-doping standpoint [11 • ].…”
Section: Athletes With Cerebral Palsy or Central Neurologic Injurymentioning
confidence: 99%